Does the Threat of an Aversive Reaction Affect Craving of Alcohol During Cue Exposure in Alcohol Dependent Patients?

This study has been completed.
Sponsor:
Collaborator:
Institut de Recherches Scientifiques sur les Boissons
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00372749
First received: September 5, 2006
Last updated: March 25, 2011
Last verified: February 2007
  Purpose

To evaluate the effect of the threat of an aversive reaction on the response during alcohol cue exposure in alcohol dependent patients : (1) the subjective response (craving) and (2) the physiological response (heart rate and blood pressure).


Condition Intervention
Alcoholic Intoxication, Chronic
Behavioral: Aversive reaction during alcohol cue exposure

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Does the Threat of an Aversive Reaction Affect Craving of Alcohol During Cue Exposure in Alcohol Dependent Patients?

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Alcohol craving visual analogic evaluation [ Time Frame: during de study ] [ Designated as safety issue: Yes ]
    Alcohol craving visual analogic evaluation


Secondary Outcome Measures:
  • Blood Pressure and Pulse Rate [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
    Blood Pressure and Pulse Rate


Enrollment: 30
Study Start Date: October 2006
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Aversive reaction during alcohol cue exposure
    Aversive reaction during alcohol cue exposure
    Other Name: Aversive reaction during alcohol cue exposure
Detailed Description:

The efficacy of disulfiram in relapse prevention is controversial. Not only are most of the studies dated but their methodological rigor is generally poor. The major obstacle to disulfiram's effectiveness is non-compliance. No study to date has directly explored whether the threat of a disulfiram ethanol reaction (DER), provoked by the ingestion of disulfiram, has an effect on craving. Alcohol dependent patients have difficulty tolerating craving, a phenomenon that is believed to increase the probability of relapse. We propose in this study an evaluation of alcohol craving in relation to the threat of a DER compared to no threat. In both of these experimental conditions, we will use a placebo in order to avoid confounding the pharmacological effect of disulfiram with the psychological effect of the threat. Craving will be evaluated in the context of the multidimensional model of ambivalence (BREINER, STRITZKE and Lang, 1999) which provides two independent dimensions, craving and aversion.

To evaluate the effect of the threat of an aversive reaction on the response during alcohol cue exposure in alcohol dependent patients : (1) the subjective response (craving) and (2) the physiological response (heart rate and blood pressure).

  • To evaluate the correlation between the subjective and physiological responses to alcohol cue exposure in relation to the threat of an aversive reaction.
  • To evaluate the moderating effects of mood and personality on alcohol cue exposure in relation to the threat of an aversive reaction.

The design of this study is a within-subject, single-blind, randomized, and monocentric. The participants will be exposed to their habitual alcoholic drink. They will receive a placebo with two types of randomized inductions : (1) the threat of an aversive reaction and (2) no threat. The initial inclusion visit will take place a minimum of six days after the patients consumed their last alcohol beverage, the first cue exposure will take place one to seven days after the inclusion visit, and the second cue exposure will take place four to eight days after the first. This study directly benefits the patient because the experience of cue exposure provokes habituation.

The demonstration of an effect of the threat of an aversive reaction on craving may help alcohol dependent patients to better accept treatment using disulfiram as they would view it as alleviating craving instead of strictly as a punitive measure in the event of alcohol intake.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inpatients
  • Alcohol dependence
  • Detoxified since at least one week
  • Willing to abstain from alcohol for at least 6 months
  • Never treated with disulfiram

Exclusion Criteria:

  • Any contra-indication to disulfiram
  • Treated with and antidepressant or a neuroleptic medication within the 30 previous days
  • Treated with acamprosate, naltrexone, betablockers or clonidine within the 7 previous days
  • Treated with benzodiazepines within the 3 previous days (except diazepam, maximum 30 mg/d)
  • Anosmia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00372749

Locations
France
Hopital Emile Roux APHP
Limeil-Brevannes, France, 94450
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Institut de Recherches Scientifiques sur les Boissons
Investigators
Principal Investigator: Henri Jean AUBIN, MD, Assistance Publique - Hôpitaux de Paris
  More Information

No publications provided by Assistance Publique - Hôpitaux de Paris

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Myriem CARRIER, Department of Clinical Research of developpement
ClinicalTrials.gov Identifier: NCT00372749     History of Changes
Other Study ID Numbers: P051058
Study First Received: September 5, 2006
Last Updated: March 25, 2011
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Alcohol dependence
Craving
Disulfiram
Cue exposure

Additional relevant MeSH terms:
Alcoholic Intoxication
Alcoholism
Alcohol-Related Disorders
Substance-Related Disorders
Mental Disorders
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Central Nervous System Depressants
Physiological Effects of Drugs
Central Nervous System Agents

ClinicalTrials.gov processed this record on July 24, 2014